These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19519459)

  • 1. HM74a agonists: will they be the new generation of nicotinic acid?
    Martres P
    Curr Top Med Chem; 2009; 9(5):428-35. PubMed ID: 19519459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic acid: an old drug with a promising future.
    Bodor ET; Offermanns S
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S68-75. PubMed ID: 18037924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
    Offermanns S
    Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.
    Vosper H
    Br J Pharmacol; 2009 Sep; 158(2):429-41. PubMed ID: 19627285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride modulation by acifran analogs: activity towards the niacin high and low affinity G protein-coupled receptors HM74A and HM74.
    Mahboubi K; Witman-Jones T; Adamus JE; Letsinger JT; Whitehouse D; Moorman AR; Sawicki D; Bergenhem N; Ross SA
    Biochem Biophys Res Commun; 2006 Feb; 340(2):482-90. PubMed ID: 16389067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A.
    Tang Y; Zhou L; Gunnet JW; Wines PG; Cryan EV; Demarest KT
    Biochem Biophys Res Commun; 2006 Jun; 345(1):29-37. PubMed ID: 16674924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats.
    Shen HC; Ding FX; Deng Q; Wilsie LC; Krsmanovic ML; Taggart AK; Carballo-Jane E; Ren N; Cai TQ; Wu TJ; Wu KK; Cheng K; Chen Q; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2009 Apr; 52(8):2587-602. PubMed ID: 19309152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acid as a lipid-modifying drug--a review.
    Julius U; Fischer S
    Atheroscler Suppl; 2013 Jan; 14(1):7-13. PubMed ID: 23357134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin: chemical forms, bioavailability, and health effects.
    MacKay D; Hathcock J; Guarneri E
    Nutr Rev; 2012 Jun; 70(6):357-66. PubMed ID: 22646128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics.
    Dunbar RL; Goel H; Tuteja S; Song WL; Nathanson G; Babar Z; Lalic D; Gelfand JM; Rader DJ; Grove GL
    J Lipid Res; 2017 Apr; 58(4):783-797. PubMed ID: 28119443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b.
    Semple G; Skinner PJ; Cherrier MC; Webb PJ; Sage CR; Tamura SY; Chen R; Richman JG; Connolly DT
    J Med Chem; 2006 Feb; 49(4):1227-30. PubMed ID: 16480258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acid: pharmacological effects and mechanisms of action.
    Gille A; Bodor ET; Ahmed K; Offermanns S
    Annu Rev Pharmacol Toxicol; 2008; 48():79-106. PubMed ID: 17705685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.
    Karas RH; Kashyap ML; Knopp RH; Keller LH; Bajorunas DR; Davidson MH
    Am J Cardiovasc Drugs; 2008; 8(2):69-81. PubMed ID: 18422390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epidermoid A431 cells express functional nicotinic acid receptor HM74a.
    Zhou L; Tang Y; Cryan EV; Demarest KT
    Mol Cell Biochem; 2007 Jan; 294(1-2):243-8. PubMed ID: 17124637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a new extended-release formulation of nicotinic acid in Korean adults with mixed dyslipidemia: an 8-week, multicenter, prospective, randomized, double-blind, and placebo-controlled trial.
    Kim SH; Kim MK; Lee HY; Kang HJ; Kim YJ; Park BJ; Kim HS
    Clin Ther; 2011 Oct; 33(10):1357-64. PubMed ID: 21955937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What restricts the clinical use of nicotinic acid?
    Kei A; Liberopoulos EN; Elisaf MS
    Curr Vasc Pharmacol; 2011 Jul; 9(4):521-30. PubMed ID: 21314634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.